Dynamic change of coagulation and anticoagulation markers of patients with acute cerebral infarction during intravenous urokinase thrombolysis

Neurological Research

Volumn 28, Issue 1, 2006, Pages 46-49

  Ji, Xunming ^a   Meng, Ran ^a   Zhou, Jin ^b   Ling, Feng ^a   Jia, Jianping ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Acute; Blood coagulation; Cerebrovascular; Stroke; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; BIOCHEMICAL MARKER; FIBRINOGEN; HEPARIN; PROTHROMBIN; THROMBIN; THROMBOPLASTIN; UROKINASE;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOT LYSIS; BLOOD CLOTTING; BRAIN INFARCTION; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PATIENT MONITORING; PROTHROMBIN TIME; STATISTICAL SIGNIFICANCE; THROMBIN TIME; TREATMENT OUTCOME; UNITED KINGDOM;

AGED; BIOLOGICAL MARKERS; BLOOD COAGULATION; CEREBRAL INFARCTION; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; NONLINEAR DYNAMICS; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; THROMBIN TIME; THROMBOPLASTIN; TIME FACTORS; URINARY PLASMINOGEN ACTIVATOR;

EID: 32044471876     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164106X91861     Document Type: Article

References (28)

1. Ramee SR, Subramanian R, Felberg RA, et al. Catheter-based treatment for patients with acute ischemic stroke ineligible for intravenous thrombolysis. Stroke 2004; 35: e109-e112
2. Ducrocq X, Bracard S, Taillandier L, et al. Comparison of intravenous and intra-arterial urokinase thrombolysis for acute ischaemic stroke. J Neuroradiol 2005; 32: 26-32
3. Mielke O, Wardlaw J, Liu M. Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke. Cochrane Database Syst Rev 2004; (4): CD000514
4. Brandt T. Diagnosis and thrombolytic therapy of acute basilar artery occlusion: A review. Clin Exp Hypertens 2002; 24: 611-622
5. Kim JS, Yoon SS, Kwon SU, et al. Treatment of acute cerebral infarction with arginine esterase: A control study with heparin. Cerebrovasc Dis 2001; 11: 251-256
6. Ducrocq X, Bracard S, Taillandier L, et al. Comparison of intravenous and intra-arterial urokinase thrombolysis for acute ischaemic stroke. J Neuroradiol 2005; 32: 26-32
7. Schellinger PD, Chalela JA, Kang DW, et al. Diagnostic and prognostic value of early MR Imaging vessel signs in hyperacute stroke patients imaged <3 hours and treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol 2005; 26: 618-624
8. Wu JH, Siddiqui K, Diamond SL. Transport phenomena and clot dissolution therapy: an experimental investigation of diffusion-controlled and permeation-enhanced fibrinolysis. Thromb Haemost 1994; 72: 105-112
9. Abboud H, Amarenco P. Thrombolysis and acute cerebral infarction. Med Sci 2004; 20: 1104-1108
10. Randall T, Higashida, Anthony J, et al. Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003; 34: e109-e137
11. Stief TW, Weippert M, Kretschmer V, et al. Arginine inhibits hemostasis activation. Thromb Res 2001; 104: 265-274
12. Oberhofer D, Kucisec-Tepes N, Skok J, et al. Coagulation tests in septic surgical patients Acta Med Croatica 2004; 58: 389-394
13. Ali A, Hashem M, Rosman HS, et al. Glycoprotein IIb/IIIa receptor antagonists and risk of bleeding: A single-center experience in 1020 patients. J Clin Pharmacol 2004; 44: 1328-1332
14. Lee MS, Wali AU, Menon V, et al. The determinants of activated partial thromboplastin time, relation of activated partial thromboplastin time to clinical outcomes, and optimal dosing regimens for heparin treated patients with acute coronary syndromes: A review of GUSTO-IIb. J Thromb Thrombolysis 2002; 14: 91-101
15. Gladstone JP, Dodick DW. Migraine and cerebral white matter lesions: When to suspect cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Neurologist 2005; 11: 19-29
16. Ionita CC, Xavier AR, Kirmani JF, et al. What proportion of stroke is not explained by classic risk factors? Prev Cardiol 2005; 8: 41-46
17. Meschia JF, Brott TG, Brown RD, Jr. Genetics of cerebrovascular disorders. Mayo Clin Proc 2005; 80: 122-132
18. Helgadottir A, Gretarsdottir S, St Clair D. Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am J Hum Genet 2005; 76: 505-509
19. Baum L, Wong KS, Ng HK, et al. Methylenetetrahydrofolate reductase gene A222V polymorphism and risk of ischemic stroke. Clin Chem Lab Med 2004; 42: 1370-1376
20. Kim H, Friedlander Y, Longstreth WT, Jr, et al. Family history as a risk factor for stroke in young women. Am J Prev Med 2004; 27: 391-396
21. Chen CH, Lo YK, Ke D, et al. Platelet glycoprotein la C807T, Ib C3550T, and IIIa PI(A1/A2) polymorphisms and ischemic stroke in young Taiwanese. J Neurol Sci 2004; 227: 1-5
22. Wei Y, Liu Y, Huang R, et al. Intercellular adhesion molecule-1 gene K469E polymorphism and genetic susceptibility of ischemic stroke in Chinese Zhuang populations. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2005; 22: 305-308
23. Lin YC, Chang YM, Yu JM, et al. Toll-like receptor 4 gene C119A but not Asp299Gly polymorphism is associated with ischemic stroke among ethnic Chinese in Taiwan. Atherosclerosis 2005; 180: 305-309
24. Casas JP, Hingorani AD, Bautista LE, et al. Meta-analysis of genetic studies in ischemic stroke: Thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol 2004; 61: 1652-1661
25. Mukamal KJ, Ascherio A, Mittleman MA, et al. Alcohol and risk for ischemic stroke in men: The role of drinking patterns and usual beverage. Ann Intern Med 2005; 142 (1): 11-19
26. Ionita CC, Xavier AR, Kirmani JF, et al. What proportion of stroke is not explained by classic risk factors? Prev Cardiol 2005; 8: 41-46
27. Roy S, Brosstad F, Sakariassen KS. Selective thrombolysis in acute deep vein thrombosis: evaluation of adjuvant therapy in vivo. Cardiovasc Intervent Radiol 1999; 22: 403-410
28. Leigh R, Zaidat OO, Suri MF, et al. Predictors of hyperacute clinical worsening in ischemic stroke patients receiving thrombolytic therapy. Stroke 2004; 35: 1903-1907